Group B streptococcus neonatal invasive infections, France 2007-2012

Clinical Microbiology and Infection

Volumn 21, Issue 10, 2015, Pages 910-916

  Joubrel, C ^a,b,c,d,e   Tazi, A ^a,b,c,d,e   Six, A ^d,e   Dmytruk, N ^a,b,c   Touak, G ^a,b,c   Bidet, P ^f   Raymond, J ^a,c,d   Trieu Cuot, P ^g,h   Fouet, A ^b,c,d,e   Kerneis S ^a,b,c,d   Poyart, C ^a,b,c,d,e,h  

^a Institut Cochin   (France)

^b Hotel Dieu 1 Pl Parvis Notre D   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSTITUT COCHIN   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g INSTITUT PASTEUR   (France)

^h CNRS   (France)

Author keywords

Capsular serotype; Group B streptococcus; Hypervirulent CC17; Meningitis; Neonatal infections; Risk factors; Streptococcus agalactiae

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; BACTERIAL POLYSACCHARIDE; GENTAMICIN; KANAMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; EPIDEMIC; FEMALE; FRANCE; GESTATIONAL AGE; HUMAN; INCIDENCE; INDUSTRIALIZATION; LOW BIRTH WEIGHT; MALE; NEWBORN; NEWBORN INFECTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; CLASSIFICATION; INFANT; ISOLATION AND PURIFICATION; MENINGITIS, BACTERIAL; MICROBIOLOGY; MORTALITY; SEROTYPE; STREPTOCOCCAL INFECTIONS; SURVIVAL ANALYSIS;

BACTEREMIA; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; RISK FACTORS; SEROGROUP; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SURVIVAL ANALYSIS;

EID: 84942192726     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.039     Document Type: Article

References (23)

1. Edwards M.S., Nizet V., Baker C.J. Group B streptococcal infections. Infectious diseases of the fetus and newborn infant 2011, 419-469. Elsevier, Philadelphia, PA. 7th ed. J.S. Remington, J.O. Klein, C.B. Wilson, V. Nizet, Y. Maldonado (Eds.).
2. Phares C.R., Lynfield R., Farley M.M., Mohle-Boetani J., Harrison L.H., Petit S., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299(17):2056-2065.
3. Tazi A., Disson O., Bellais S., Bouaboud A., Dmytruk N., Dramsi S., et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med 2010, 207(11):2313-2322.
4. Schrag S.J., Verani J.R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 2013, 31(Suppl. 4):D20-D26.
5. Edmond K.M., Kortsalioudaki C., Scott S., Schrag S.J., Zaidi A.K., Cousens S., et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012, 379(9815):547-556.
6. Libster R., Edwards K.M., Levent F., Edwards M.S., Rench M.A., Castagnini L.A., et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012, 130(1):e8-15.
7. Bohnsack J.F., Whiting A., Gottschalk M., Dunn D.M., Weiss R., Azimi P.H., et al. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six US Academic Centers from 1995 to 1999. J Clin Microbiol 2008, 46(4):1285-1291.
8. Manning S.D., Springman A.C., Lehotzky E., Lewis M.A., Whittam T.S., Davies H.D. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009, 47(4):1143-1148.
9. Lamy M.C., Dramsi S., Billoët A., Réglier-Poupet H., Tazi A., Raymond J., et al. Rapid detection of the 'highly virulent' group B Streptococcus ST-17 clone. Microbes Infect 2006, 8(7):1714-1722.
10. Poyart C., Tazi A., Réglier-Poupet H., Billoët A., Tavares N., Raymond J., et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007, 45(6):1985-1988.
11. Da Cunha V., Davies M.R., Douarre P.E., Rosinski-Chupin I., Margarit I., Spinali S., et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun 2014, 5:4544. 10.1038/ncomms5544.
12. Malhotra-Kumar S., Lammens C., Piessens J., Goossens H. Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother 2005, 49(11):4798-4800.
13. Georget-Bouquinet E., Bingen E., Aujard Y., Levy C., Cohen R. [Group B streptococcal meningitis clinical, biological and evolutive features in children]. Arch Pediatr 2008, 15(Suppl. 3):S126-S132. Groupe des Pediatres et Microbiologistes de l'Observatoire National des Meningites Bacteriennes de l'Enfant.
14. Berardi A., Lugli L., Baronciani D., Creti R., Rossi K., Ciccia M., et al. Group B streptococcal infections in a northern region of Italy. Pediatrics 2007, 120(3):e487-e493.
15. Puopolo K.M., Madoff L.C., Eichenwald E.C. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005, 115(5):1240-1246.
16. Le Doare K., Heath P.T. An overview of global GBS epidemiology. Vaccine 2013, 31(Suppl. 4):D7-D12.
17. MacFarquhar J.K., Jones T.F., Woron A.M., Kainer M.A., Whitney C.G., Beall B., et al. Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit. Am J Infect Control 2010, 38(4):283-288.
18. Bekker V., Bijlsma M.W., van de Beek D., Kuijpers T.W., van der Ende A. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: A nationwide surveillance study. Lancet Infect Dis 2014, 14(11):1083-1089.
19. Seo H.S., Minasov G., Seepersaud R., Doran K.S., Dubrovska I., Shuvalova L., et al. Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae. J Biol Chem 2013, 288(50):35982-35996.
20. Seifert K.N., Adderson E.E., Whiting A.A., Bohnsack J.F., Crowley P.J., Brady L.J. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 2006, 152(Pt 4):1029-1040.
21. Gaschignard J., Levy C., Romain O., Cohen R., Bingen E., Aujard Y., et al. Neonatal bacterial meningitis: 444 cases in 7 years. Pediatr Infect Dis J 2011, 30(3):212-217.
22. Epalza C., Goetghebuer T., Hainaut M., Prayez F., Barlow P., Dediste A., et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010, 126(3):e631-e638.
23. Leineweber B., Grote V., Schaad U.B., Heininger U. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 2004, 23(4):361-363.